Result of AGM

RNS Number : 1283L

Kromek Group PLC

08 September 2021

 

8 September 2021

Kromek Group plc

("Kromek" or the "Group")

Result of AGM

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, announces that at its Annual General Meeting ("AGM"), held earlier today, all resolutions were duly passed.

Details of the proxy voting results, which should be read alongside the Notice of AGM, are below:

Resolution	Votes for*		Votes against		Votes withheld	Total proxy votes
	No. of votes	% of votes cast**	No. of votes	% of votes cast**	No. of votes
1	133,777,364	89.54	15,624,010	10.46	54,217	149,455,591
2	147,974,523	99.79	318,496	0.21	1,162,572	149,455,591
3	148,094,523	99.87	198,496	0.13	1,162,572	149,455,591
4	147,966,054	99.78	326,965	0.22	1,162,572	149,455,591
5	140,307,685	94.73	7,801,643	5.27	1,346,263	149,455,591
6	149,160,289	99.87	192,048	0.13	103,254	149,455,591
7	146,992,772	99.73	391,383	0.27	2,071,436	149,455,591
8	142,130,784	96.38	5,337,678	3.62	1,987,129	149,455,591
9	139,210,426	94.39	8,268,036	5.61	1,977,129	149,455,591

* Includes discretionary votes

** Excludes withheld votes

For further information, please contact:

Kromek Group plc
Arnab Basu, CEO Paul Farquhar, CFO	[phone]
Cenkos Securities plc (Nominated Adviser and Broker)
Camilla Hume/Giles Balleny (NOMAD) Julian Morse (Sales)	[phone]
Luther Pendragon (PR)
Harry Chathli, Claire Norbury	[phone]

About Kromek Group plc

Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over 150 full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

 

END

 

 

RAGEAENPEEPFEFA